Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- ORIONIndependent statistical analysis of A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ORIONIndependent statistical analysis of EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORION-10Independent statistical analysis of Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ORKAIndependent statistical analysis of Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866423).
- Orthostatic Hypotension Treatment on Rehab Unit: Complete Statistical AnalysisIndependent statistical analysis of Orthostatic Hypotension Treatment on Rehab Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030874).
- ORTHOVISC Shoulder Osteoarthritis Study: Complete Statistical AnalysisIndependent statistical analysis of ORTHOVISC Shoulder Osteoarthritis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00436969).
- orvepitant MDDIndependent statistical analysis of A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…
- Osia CPT Code Study: Complete Statistical AnalysisIndependent statistical analysis of Osia CPT Code Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320407).
- Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: Complete Statistical AnalysisIndependent statistical analysis of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03414814).
- OSKIRA-Asia-1Independent statistical analysis of Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oslo-CoMetIndependent statistical analysis of Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OSPREY-AHFIndependent statistical analysis of Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04334668).
- Osteoarthritis Shoulder Injection Study: Complete Statistical AnalysisIndependent statistical analysis of Osteoarthritis Shoulder Injection Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03586687).
- OsteosarcomaIndependent statistical analysis of Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01336803).
- OSTROIndependent statistical analysis of Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OSU Plate Waste Study: Complete Statistical AnalysisIndependent statistical analysis of OSU Plate Waste Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02790502).
- OTBB2Independent statistical analysis of Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- OTDIndependent statistical analysis of Testing THRIVE 365 for Black Sexual Minority Men (On The Daily): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OTO-313 in Subjects With Subjective Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of OTO-313 in Subjects With Subjective Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03918109).
- OTT15-04Independent statistical analysis of Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the…
- Otteroo Case Series: Complete Statistical AnalysisIndependent statistical analysis of Otteroo Case Series: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502265).
- OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate…
- OU-SCC-PI-4GIndependent statistical analysis of PARP Inhibition for Gliomas (PI-4G or π4g): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05297864).
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair: Complete Statistical AnalysisIndependent statistical analysis of Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535301).
- OutgrowersIndependent statistical analysis of Stimulating Private Sector Malaria Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01397851).
- Outlook Quality of Life Intervention: Complete Statistical AnalysisIndependent statistical analysis of Outlook Quality of Life Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00784095).
- Outpatient and Home Advanced Rehabilitation Therapeutics Using Jintronix Virtual Reality Telerehabilitation System: Complete Statistical AnalysisIndependent statistical analysis of Outpatient and Home Advanced Rehabilitation Therapeutics Using Jintronix Virtual Reality Telerehabilitation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OVATIONIndependent statistical analysis of Optimal VAsopressor titraTION Pilot Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01800877).
- Over Active Bladder Patients Having Sling Surgery: Complete Statistical AnalysisIndependent statistical analysis of Over Active Bladder Patients Having Sling Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852696).
- Overnight Pant Study for Children With Nocturnal Enuresis: Complete Statistical AnalysisIndependent statistical analysis of Overnight Pant Study for Children With Nocturnal Enuresis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05178641).
- Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS: Complete Statistical AnalysisIndependent statistical analysis of Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909141).
- Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter’s Syndrome, Refractory CLL and PLL: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418093).
- Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oxidative Stress in Asthma: Complete Statistical AnalysisIndependent statistical analysis of Oxidative Stress in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512547).
- OXT-PWSIndependent statistical analysis of Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor: Complete Statistical AnalysisIndependent statistical analysis of Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Oxytocin and Affect Processing in Posttraumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin and Affect Processing in Posttraumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02546570).
- Oxytocin Effects on Cardiac Electrophysiology: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Effects on Cardiac Electrophysiology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01780337).
- Oxytocin Pathways and the Health Effects of Human-Animal Interaction: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Pathways and the Health Effects of Human-Animal Interaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03852264).
- Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058251).
- Oxytocin, Alcohol Craving, and Intimate Partner Aggression: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin, Alcohol Craving, and Intimate Partner Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03046836).
- OZGAMIndependent statistical analysis of Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02431650).